5,7-dimethyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]imidazo[5,1-f][1,2,4]triazin-4-one;1,3-dimethyl-5-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrazolo[5,4-d]pyrimidin-4-one;1-(3-methylimidazol-4-yl)-3-[3-[(3S,5S)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]propan-1-one;5-methyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-7-morpholin-4-ylimidazo[5,1-f][1,2,4]triazin-4-one;5-methyl-2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrido[1,2-a]pyrazine-1,6-dione;7-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrimido[1,2-c]pyrimidine-2,6-dione

C150H153N37O24 — CID 159986245

About 5,7-dimethyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]imidazo[5,1-f][1,2,4]triazin-4-one;1,3-dimethyl-5-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrazolo[5,4-d]pyrimidin-4-one;1-(3-methylimidazol-4-yl)-3-[3-[(3S,5S)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]propan-1-one;5-methyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-7-morpholin-4-ylimidazo[5,1-f][1,2,4]triazin-4-one;5-methyl-2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrido[1,2-a]pyrazine-1,6-dione;7-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrimido[1,2-c]pyrimidine-2,6-dione

5,7-dimethyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]imidazo[5,1-f][1,2,4]triazin-4-one;1,3-dimethyl-5-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrazolo[5,4-d]pyrimidin-4-one;1-(3-methylimidazol-4-yl)-3-[3-[(3S,5S)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]propan-1-one;5-methyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-7-morpholin-4-ylimidazo[5,1-f][1,2,4]triazin-4-one;5-methyl-2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrido[1,2-a]pyrazine-1,6-dione;7-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrimido[1,2-c]pyrimidine-2,6-dione (PubChem CID 159986245) has the molecular formula C150H153N37O24 and a molecular weight of 2858.11 g/mol. Its IUPAC name is 5,7-dimethyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]imidazo[5,1-f][1,2,4]triazin-4-one;1,3-dimethyl-5-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrazolo[5,4-d]pyrimidin-4-one;1-(3-methylimidazol-4-yl)-3-[3-[(3S,5S)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]propan-1-one;5-methyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-7-morpholin-4-ylimidazo[5,1-f][1,2,4]triazin-4-one;5-methyl-2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrido[1,2-a]pyrazine-1,6-dione;7-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrimido[1,2-c]pyrimidine-2,6-dione.

Molecular Properties

• Compound Name: 5,7-dimethyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]imidazo[5,1-f][1,2,4]triazin-4-one;1,3-dimethyl-5-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrazolo[5,4-d]pyrimidin-4-one;1-(3-methylimidazol-4-yl)-3-[3-[(3S,5S)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]propan-1-one;5-methyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-7-morpholin-4-ylimidazo[5,1-f][1,2,4]triazin-4-one;5-methyl-2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrido[1,2-a]pyrazine-1,6-dione;7-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrimido[1,2-c]pyrimidine-2,6-dione
• PubChem CID: 159986245
• Molecular Formula: C150H153N37O24
• Molecular Weight: 2858.11 g/mol
• Exact Mass: 2856.19
• IUPAC Name: 5,7-dimethyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]imidazo[5,1-f][1,2,4]triazin-4-one;1,3-dimethyl-5-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrazolo[5,4-d]pyrimidin-4-one;1-(3-methylimidazol-4-yl)-3-[3-[(3S,5S)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]propan-1-one;5-methyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-7-morpholin-4-ylimidazo[5,1-f][1,2,4]triazin-4-one;5-methyl-2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrido[1,2-a]pyrazine-1,6-dione;7-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrimido[1,2-c]pyrimidine-2,6-dione
• SMILES: Cc1ccc([C@@H]2C[C@@H](c3noc(CCC(=O)c4cncn4C)n3)CO2)cc1.Cc1ccc([C@H]2C[C@H](c3noc(Cn4ccc5nc(=O)ccn5c4=O)n3)CO2)cc1.Cc1ccc([C@H]2C[C@H](c3noc(Cn4ccn5c(=O)cccc5c4=O)n3)CO2)cc1.Cc1ccc([C@H]2C[C@H](c3noc(Cn4cnc5c(c(C)nn5C)c4=O)n3)CO2)cc1.Cc1ccc([C@H]2C[C@H](c3noc(Cn4cnn5c(C)nc(C)c5c4=O)n3)CO2)cc1.Cc1ccc([C@H]2C[C@H](c3noc(Cn4cnn5c(N6CCOCC6)nc(C)c5c4=O)n3)CO2)cc1.Cc1ccc([C@H]2C[C@H](c3noc(Cn4nc5cccc(C)n5c4=O)n3)CO2)cc1
• InChI: InChI=1S/C24H27N7O4.C22H20N4O4.2C21H22N6O3.C21H19N5O4.C21H21N5O3.C20H22N4O3/c1-15-3-5-17(6-4-15)19-11-18(13-34-19)22-27-20(35-28-22)12-30-14-25-31-21(23(30)32)16(2)26-24(31)29-7-9-33-10-8-29;1-14-5-7-15(8-6-14)18-11-16(13-29-18)21-23-19(30-24-21)12-25-9-10-26-17(22(25)28)3-2-4-20(26)27;1-12-4-6-14(7-5-12)16-8-15(10-29-16)19-23-17(30-25-19)9-27-11-22-20-18(21(27)28)13(2)24-26(20)3;1-12-4-6-15(7-5-12)17-8-16(10-29-17)20-24-18(30-25-20)9-26-11-22-27-14(3)23-13(2)19(27)21(26)28;1-13-2-4-14(5-3-13)16-10-15(12-29-16)20-23-19(30-24-20)11-25-8-6-17-22-18(27)7-9-26(17)21(25)28;1-13-6-8-15(9-7-13)17-10-16(12-28-17)20-22-19(29-24-20)11-25-21(27)26-14(2)4-3-5-18(26)23-25;1-13-3-5-14(6-4-13)18-9-15(11-26-18)20-22-19(27-23-20)8-7-17(25)16-10-21-12-24(16)2/h3-6,14,18-19H,7-13H2,1-2H3;2-10,16,18H,11-13H2,1H3;4-7,11,15-16H,8-10H2,1-3H3;4-7,11,16-17H,8-10H2,1-3H3;2-9,15-16H,10-12H2,1H3;3-9,16-17H,10-12H2,1-2H3;3-6,10,12,15,18H,7-9,11H2,1-2H3/t18-,19+;16-,18+;15-,16+;16-,17+;15-,16+;16-,17+;15-,18+/m0000001/s1
• InChIKey: OGJIGXMWERFEKN-RETWKVANSA-N
• XLogP: 17.19
• TPSA: 680.65 Ų
• H-Bond Acceptors: 61
• Rotatable Bonds: 31
• Heavy Atoms: 211
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2858.11
LogP ≤ 5	17.19
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	61

Frequently Asked Questions

What is the IUPAC name of 5,7-dimethyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]imidazo[5,1-f][1,2,4]triazin-4-one;1,3-dimethyl-5-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrazolo[5,4-d]pyrimidin-4-one;1-(3-methylimidazol-4-yl)-3-[3-[(3S,5S)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]propan-1-one;5-methyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-7-morpholin-4-ylimidazo[5,1-f][1,2,4]triazin-4-one;5-methyl-2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrido[1,2-a]pyrazine-1,6-dione;7-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrimido[1,2-c]pyrimidine-2,6-dione?

The IUPAC name of 5,7-dimethyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]imidazo[5,1-f][1,2,4]triazin-4-one;1,3-dimethyl-5-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrazolo[5,4-d]pyrimidin-4-one;1-(3-methylimidazol-4-yl)-3-[3-[(3S,5S)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]propan-1-one;5-methyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-7-morpholin-4-ylimidazo[5,1-f][1,2,4]triazin-4-one;5-methyl-2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrido[1,2-a]pyrazine-1,6-dione;7-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrimido[1,2-c]pyrimidine-2,6-dione (CID 159986245) is 5,7-dimethyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]imidazo[5,1-f][1,2,4]triazin-4-one;1,3-dimethyl-5-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrazolo[5,4-d]pyrimidin-4-one;1-(3-methylimidazol-4-yl)-3-[3-[(3S,5S)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]propan-1-one;5-methyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-7-morpholin-4-ylimidazo[5,1-f][1,2,4]triazin-4-one;5-methyl-2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrido[1,2-a]pyrazine-1,6-dione;7-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrimido[1,2-c]pyrimidine-2,6-dione.

What is the SMILES notation for 5,7-dimethyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]imidazo[5,1-f][1,2,4]triazin-4-one;1,3-dimethyl-5-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrazolo[5,4-d]pyrimidin-4-one;1-(3-methylimidazol-4-yl)-3-[3-[(3S,5S)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]propan-1-one;5-methyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-7-morpholin-4-ylimidazo[5,1-f][1,2,4]triazin-4-one;5-methyl-2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrido[1,2-a]pyrazine-1,6-dione;7-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrimido[1,2-c]pyrimidine-2,6-dione?

The canonical SMILES for 5,7-dimethyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]imidazo[5,1-f][1,2,4]triazin-4-one;1,3-dimethyl-5-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrazolo[5,4-d]pyrimidin-4-one;1-(3-methylimidazol-4-yl)-3-[3-[(3S,5S)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]propan-1-one;5-methyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-7-morpholin-4-ylimidazo[5,1-f][1,2,4]triazin-4-one;5-methyl-2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrido[1,2-a]pyrazine-1,6-dione;7-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrimido[1,2-c]pyrimidine-2,6-dione is Cc1ccc([C@@H]2C[C@@H](c3noc(CCC(=O)c4cncn4C)n3)CO2)cc1.Cc1ccc([C@H]2C[C@H](c3noc(Cn4ccc5nc(=O)ccn5c4=O)n3)CO2)cc1.Cc1ccc([C@H]2C[C@H](c3noc(Cn4ccn5c(=O)cccc5c4=O)n3)CO2)cc1.Cc1ccc([C@H]2C[C@H](c3noc(Cn4cnc5c(c(C)nn5C)c4=O)n3)CO2)cc1.Cc1ccc([C@H]2C[C@H](c3noc(Cn4cnn5c(C)nc(C)c5c4=O)n3)CO2)cc1.Cc1ccc([C@H]2C[C@H](c3noc(Cn4cnn5c(N6CCOCC6)nc(C)c5c4=O)n3)CO2)cc1.Cc1ccc([C@H]2C[C@H](c3noc(Cn4nc5cccc(C)n5c4=O)n3)CO2)cc1.

What is the InChIKey of 5,7-dimethyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]imidazo[5,1-f][1,2,4]triazin-4-one;1,3-dimethyl-5-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrazolo[5,4-d]pyrimidin-4-one;1-(3-methylimidazol-4-yl)-3-[3-[(3S,5S)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]propan-1-one;5-methyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-7-morpholin-4-ylimidazo[5,1-f][1,2,4]triazin-4-one;5-methyl-2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrido[1,2-a]pyrazine-1,6-dione;7-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrimido[1,2-c]pyrimidine-2,6-dione?

The InChIKey is OGJIGXMWERFEKN-RETWKVANSA-N. The full InChI is InChI=1S/C24H27N7O4.C22H20N4O4.2C21H22N6O3.C21H19N5O4.C21H21N5O3.C20H22N4O3/c1-15-3-5-17(6-4-15)19-11-18(13-34-19)22-27-20(35-28-22)12-30-14-25-31-21(23(30)32)16(2)26-24(31)29-7-9-33-10-8-29;1-14-5-7-15(8-6-14)18-11-16(13-29-18)21-23-19(30-24-21)12-25-9-10-26-17(22(25)28)3-2-4-20(26)27;1-12-4-6-14(7-5-12)16-8-15(10-29-16)19-23-17(30-25-19)9-27-11-22-20-18(21(27)28)13(2)24-26(20)3;1-12-4-6-15(7-5-12)17-8-16(10-29-17)20-24-18(30-25-20)9-26-11-22-27-14(3)23-13(2)19(27)21(26)28;1-13-2-4-14(5-3-13)16-10-15(12-29-16)20-23-19(30-24-20)11-25-8-6-17-22-18(27)7-9-26(17)21(25)28;1-13-6-8-15(9-7-13)17-10-16(12-28-17)20-22-19(29-24-20)11-25-21(27)26-14(2)4-3-5-18(26)23-25;1-13-3-5-14(6-4-13)18-9-15(11-26-18)20-22-19(27-23-20)8-7-17(25)16-10-21-12-24(16)2/h3-6,14,18-19H,7-13H2,1-2H3;2-10,16,18H,11-13H2,1H3;4-7,11,15-16H,8-10H2,1-3H3;4-7,11,16-17H,8-10H2,1-3H3;2-9,15-16H,10-12H2,1H3;3-9,16-17H,10-12H2,1-2H3;3-6,10,12,15,18H,7-9,11H2,1-2H3/t18-,19+;16-,18+;15-,16+;16-,17+;15-,16+;16-,17+;15-,18+/m0000001/s1.

What are the key properties of 5,7-dimethyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]imidazo[5,1-f][1,2,4]triazin-4-one;1,3-dimethyl-5-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrazolo[5,4-d]pyrimidin-4-one;1-(3-methylimidazol-4-yl)-3-[3-[(3S,5S)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]propan-1-one;5-methyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-7-morpholin-4-ylimidazo[5,1-f][1,2,4]triazin-4-one;5-methyl-2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrido[1,2-a]pyrazine-1,6-dione;7-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrimido[1,2-c]pyrimidine-2,6-dione?

5,7-dimethyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]imidazo[5,1-f][1,2,4]triazin-4-one;1,3-dimethyl-5-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrazolo[5,4-d]pyrimidin-4-one;1-(3-methylimidazol-4-yl)-3-[3-[(3S,5S)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]propan-1-one;5-methyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-7-morpholin-4-ylimidazo[5,1-f][1,2,4]triazin-4-one;5-methyl-2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrido[1,2-a]pyrazine-1,6-dione;7-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrimido[1,2-c]pyrimidine-2,6-dione has a molecular weight of 2858.11 g/mol, XLogP of 17.19, 31 rotatable bonds, 0 hydrogen bond donors, and 61 hydrogen bond acceptors.

Where does this data come from?

All data for 5,7-dimethyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]imidazo[5,1-f][1,2,4]triazin-4-one;1,3-dimethyl-5-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrazolo[5,4-d]pyrimidin-4-one;1-(3-methylimidazol-4-yl)-3-[3-[(3S,5S)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]propan-1-one;5-methyl-3-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-7-morpholin-4-ylimidazo[5,1-f][1,2,4]triazin-4-one;5-methyl-2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;2-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrido[1,2-a]pyrazine-1,6-dione;7-[[3-[(3R,5R)-5-(4-methylphenyl)oxolan-3-yl]-1,2,4-oxadiazol-5-yl]methyl]pyrimido[1,2-c]pyrimidine-2,6-dione is sourced from PubChem (CID 159986245), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).